We scan new podcasts and send you the top 5 insights daily.
Mission-driven healthcare concepts cannot expand across corporate clients without clear financial justification. Providing employer partners with queryable analytic portals demonstrating documented satisfaction and multi-year cost reductions makes preventative screening economically compelling for executive decision-makers.
Preventing a chronic disease like type 2 diabetes saves hundreds of thousands of dollars per patient. However, due to high customer churn and standard one-year contracts, insurance companies see no long-term financial upside in prevention, as another company will likely benefit from their investment.
To get adopted, a technology must speak three languages. It needs to provide excellent clinical outcomes for physicians, operational efficiency for staff, and a positive economic impact for hospital administrators. Excelling in only one area is not enough.
The core of value-based care is a business model where preventing adverse events like strokes is more profitable than treating them. This fundamental financial alignment, not just quality measures, drives organizations like Kaiser to invest in team-based care and proactive protocols, a reality that clinicians within the system may not even perceive.
General Catalyst's CEO highlights a core flaw in healthcare: insurance providers don't reimburse for longevity or preventative care because customers frequently switch plans, preventing insurers from capturing long-term ROI. The first company to solve this misalignment and make longevity "financeable" will unlock a massive market.
Administering health screenings directly at job sites produces substantially higher compliance rates than conventional outpatient facilities relying on reminder mailers. Consistently appearing where employees already spend their days removes friction and helps employers reduce lost productivity and late-stage diagnostic expenses.
Instead of ad-hoc pilots, structure them to quantify value across three pillars: incremental revenue (e.g., reduced churn), tangible cost savings (e.g., FTE reduction), and opportunity costs (e.g., freed-up productivity). This builds a solid, co-created business case for monetization.
During the pandemic, companies adopted digital health solutions to make employees happy. Now, the focus has returned to fundamentals. Buyers demand solutions that demonstrably reduce costs, like insurance claims or sickness absenteeism, rather than just offering 'added value' perks.
Health plans have short-term incentives misaligned with long-term chronic care savings. Employers, who bear the costs longest, are the true economic buyers. By acquiring a broker and sharing in cost savings, a startup can align incentives and scale effectively.
When pitching a wellness product to B2B clients, shift the conversation from a 'nice-to-have' perk to a 'must-have' financial tool. Use data, even if anonymized, to demonstrate how your product reduces tangible costs like workers' compensation claims, making it an investment with a clear ROI.
The current healthcare model is backwards. It's more cost-effective to proactively get comprehensive diagnostics like blood work done twice a year than to rely on multiple, expensive doctor visits after symptoms appear. This preventative approach catches diseases earlier and reduces overall system costs.